Expression of neuron-specific enolase, chromogranin a, synaptophysin and Leu-7 in lung cancer cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 2, 1998, Pages 165-173

  Poola, I ^a,b   Graziano, S L ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell surface glycoprotein; Chemotherapy; Lung cancer cell lines; Neuroendocrine markers

Indexed keywords

CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG SMALL CELL CANCER; MESSENGER RNA SYNTHESIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD57; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHROMOGRANIN A; CHROMOGRANINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PHOSPHOPYRUVATE HYDRATASE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYNAPTOPHYSIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031839903     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sobin L.H.: The WHO histologcal classification of lung tumors. In: Muggia FM, Rozenczeig M, eds. Lung Cancer: Progress in Therapeutic Research. New York: Raven Press, p 83-90, 1979
2. Bunn P.A Jr., Albain K.S., Bitran J.D, Golomb H.M.: Current concepts in small cell carcinoma of the lung. Cancer 34: 269-281, 1984
3. Doria M.I., Montag A.G., Franklin W.A.: Immunophenotype of small cell lung carcinoma. Cancer. 62:1939-1944, 1988
4. Comis R.L.: Small cell carcinoma of the lung. Cancer Treat Rev 9:237-258, 1982.
5. Minna J.D., Pass H., Glatstein E and Ihde D.: Cancer of the lung, in Devita VT, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology. Philadelphia, PA Lippincott, 1989, pp 591-705.
6. Graziano S.L., Mazid R., Newman N., et al.: The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. Journal of Clinica Oncology 7: 1398-1406, 1989
7. Gazdar A. R. and Linnoila R.: The pathology of lung cancer: Clinical significance of neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J. Natl Cancer Inst. Monographs 81: 116-124, 1992.
8. Fletcher L., Rider C.C. and Taylor C.B.: Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys. Acta 452: 245, 1976.
9. Hogu A.R.: Chromogranins and neuroendocrine secretion. Lab Invest 55: 387 1986.
10. Gould V.E., Lee I., Wiedenmann B., Moll R., Chejfec G., and Franke W.W.: Synaptophysin: A novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Human Pathology 17: 979-983 1986.
11. Lanier L.L., Le A.M., Phillips J.H. and Babcock G.F.: Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J.Immunol. 131: 1789-1796 1983.
12. Gazdar A.F., Helman L.J., Israel M.A., Russell E.K., Linnoila I., Mulshine J.L., Schuller H.M. and Park J.G.: Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 48: 4078-4082 1988.
13. Addis B., Hamid Q., Ibrahm N.B. et al.: Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumors of the lung. J Pathol 153: 137-150, 1987.
14. Bergh J., Esscher T., Steinholtz L., et al.: Immunocytochemical demonstration of neuron- specific enolase (NSE) in human lung cancers. Am J Cln Pathol 84: 1-7, 1985.
15. Said J.W., Vimadalal S., Nash G. et al.: Immunoreactive neuron specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 16: 236-240, 1985.
16. Bunn P.A., Linnoila I., Minna J.D. et al.: Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrinee cells express the Leu-7 antigenic determinant present on natural killer cells. Blood 65: 764-766, 1985.
17. Wilson B.S., Lyoyd R.V.: Determination of chromogranin in neuroendocrine cell with a monoclonal antibody. Am J Pathol 115: 458-468, 1984.
18. Heppard M., Corrin B., Bennett M.H. et al.: Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumors of the lung. Histopathol 8: 171-181, 1984.
19. Gazdar A.R., Linnoila R.I., Jewett P. et al.: Natural killer (NK) cell associated antigen NKH-1 is a marker for neuroendocrine tumors of the lung. Proc Am Asso Cancer Res 28: 359, 1987 (abstr 1424)
20. Walts A.E., Said J.W., Shintaku I.P. et al.: Chromogranin as a marker of neuroendocrine cells in cytologic material-an immocytochemical study. Am J Clin Pathol 84: 273-277, 1985
21. Jensen S., Gazdar A.J., Cuttitta F., Russell E.K. and Linnoila R.J.: A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res. 50: 6068-6074 1990.
22. Graziano S.L., Pfeiffer A.M., Testa J.R., Mark G.E., Johnson B.E., Hallinan E.J., Pettengill O.S., Sorenson G.D., Tatum A.H., Brauch H., Zbar B., Ehrlich G.D. and Poiesz B.J.: Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small cell lung cancer, Genes Chromosomes and cancer. 3: 283-293, 1991.
23. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
24. Bensadon A. and Weinstein D.: Assay of protein in the presence of interfering materials. Anal. Biochem. 70: 241-250, 1976.
25. Laemmli U.K.: Nature 227: 680-685, 1970.
26. Towbin H., Staehlin T. and Gordon J.: Proc. Natl. Acad. Sci. U.S.A. 76: 4350-4354, 1979.
27. Hawkes R., Niday E. and Gordon: A dot immunoassay for monoclonal and other antibodies. J. Anal. Biochem. 119: 142-147, 1982.
28. Young R.A. and Davis R.W.: Science, 222: 778-782, 1983.
29. Sudhof T.C., Lottspeich F., Greengard P., Mehl E. and Jahn R.: A synaptic vesicle protein with a novel cytoplasmic domain and four transmembrane-regions. Science 238: 1142-1144: 1987.
30. Davis L.G., Dibner M.D. and Batty J.F.: Basic methodologies in molecular biology p 75-78 and 147-149. Elsevier Press, New York. 1986.
31. Poola I. and Lucas J.J.: Purification and characterization of an estrogen-inducible membrane glycoprotein. Evidence that it is a transferrin receptor. J. Biol. Chem. 263: 19137-19145, 1988.
32. Poola I., Mason A.B. and Lucas J.J.: The chicken oviduct and red blood cell membrane transferrin receptors are distinct molecules. Biochem. Biophys. Res. Commu. 171: 26-32, 1990
33. Poola I and Kiang J.G.: The estrogen-inducible transferrin receptor like membrane glycoprotein is related to stress regulated proteins. J. Biol. Chem. 269: 21762-21768, 1994.
34. Poola I.: The estrogen inducible 104 kDa chepenon glycoprotein binds ferric iron containing proteins: A possible role in intracellular trafficking of ison. FEBS Letters 416: 139-143 (1997) (Submitted).